Stocks
Moderna, Inc.MRNA
NASDAQHealthcareBiotechnology$52.56-1.55%
A biotechnology company focused on developing messenger RNA (mRNA)–based medicines and vaccines, with products targeting infectious diseases, rare disorders, and oncology. Its COVID-19 vaccine drove a surge in revenue during the pandemic and remains a key commercial product while the firm advances a...
Market Cap: $20.8B52W Range: $22.28 – $59.55
Congressional Interest in Moderna, Inc. (MRNA)
6 members of Congress have disclosed 17 trades in Moderna, Inc. (MRNA), a Healthcare company. The buy/sell breakdown shows 5 purchases versus 12 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
17
Unique Politicians
6
Buys
5
Sells
12
Who in Congress Is Trading MRNA?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2021-03-15 | Josh Gottheimer | sell | $1K – $15K |
| 2021-01-29 | Marie Newman | sell | $15K – $50K |